H. Service-de-néphrologie and . Pontchaillou, Rennes; 25 Service d'Immunopathologie, 26 Service de Réanimation polyvalente, AP-HP, Hôpital Saint-Louis

P. Coppo, H. Service-d-'hématologie-et-de-thérapie-cellulaire, and . Saint-antoine, Paris 06, 184 rue du Faubourg Saint-Antoine

J. Sadler, Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura, Blood, vol.112, issue.1, pp.11-19, 2008.
DOI : 10.1182/blood-2008-02-078170
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435681

C. Klaus, B. Plaimauer, J. Studt, F. Dorner, B. Lammle et al., Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura, Blood, vol.103, issue.12, pp.4514-4523, 2004.
DOI : 10.1182/blood-2003-12-4165

M. Scully, V. Mcdonald, J. Cavenagh, B. Hunt, I. Longair et al., A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura, Blood, vol.118, issue.7, pp.1746-53, 2011.
DOI : 10.1182/blood-2011-03-341131

A. Froissart, M. Buffet, A. Veyradier, P. Poullin, F. Provot et al., Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center, Critical Care Medicine, vol.40, issue.1, pp.104-115, 2012.
DOI : 10.1097/CCM.0b013e31822e9d66

M. Franchini and P. Mannucci, Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura, Blood Transfus, vol.6, issue.3, pp.127-162, 2008.

J. Hovinga, S. Vesely, D. Terrell, B. Lammle, J. George et al., Survival and relapse in patients with thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange, Blood. Ann Hematol, vol.11570, issue.86, pp.1500-11319, 1995.

M. Rose and A. Eldor, High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. The American journal of medicine, pp.437-481, 1987.

G. Rock, J. Kelton, K. Shumak, N. Buskard, D. Sutton et al., Laboratory abnormalities in thrombotic thrombocytopenic purpura, British Journal of Haematology, vol.116, issue.4, pp.1031-1037, 1998.
DOI : 10.1046/j.1365-2141.1996.d01-1800.x

J. Patton, K. Manning, D. Case, J. Owen, G. Rock et al., Serum lactate dehydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura, Am J Hematol. Canadian Apheresis Study Group. The New England journal of medicine, vol.47325, issue.12, pp.94-9393, 1991.

B. Wyllie, A. Garg, J. Macnab, G. Rock, W. Clark et al., Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura, pp.204-9488, 2004.

P. Coppo, M. Wolf, A. Veyradier, A. Bussel, S. Malot et al., Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura, British Journal of Haematology, vol.138, issue.1, pp.66-74, 2006.
DOI : 10.1182/blood-2003-11-4035
URL : https://hal.archives-ouvertes.fr/hal-00453285

H. Tsai, P. Coppo, M. Schwarzinger, M. Buffet, A. Wynckel et al., High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura, American Journal of Hematology, vol.47, issue.3, pp.251-256, 2000.
DOI : 10.1002/1096-8652(200011)65:3<251::AID-AJH13>3.0.CO;2-2

S. Ferrari, F. Scheiflinger, M. Rieger, G. Mudde, M. Wolf et al., Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity, Blood, vol.109, issue.7, pp.2815-2837, 2007.

E. Delong, D. Delong, and D. Clarke-pearson, Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach, Biometrics, vol.44, issue.3, pp.837-882, 1988.
DOI : 10.2307/2531595

. Thrombotic-thrombocytopenic-purpura, hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases, Ann Hematol, vol.79, issue.2, pp.66-72, 2000.

F. Scheiflinger, P. Knobl, B. Trattner, B. Plaimauer, G. Mohr et al., Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura, Blood, vol.102, issue.9, pp.3241-3244, 2003.
DOI : 10.1182/blood-2003-05-1616

G. Eymin, M. Andrade, M. Andresen, J. Pereira, P. Lara et al., Thrombotic thrombocytopenic purpura: experience in 18 cases and literature review] Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. The American journal of medicine, Rev Med Chil, vol.136107, issue.256, pp.1518-27573, 1999.

J. Cohen, M. Brecher, N. Bandarenko, F. Dalldorf, and P. Blatt, Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura Thrombotic thrombocytopenic purpura: a pathology review, J Clin Apher. Jama, vol.13241, issue.116, pp.1709-1719, 1979.

D. Patschan, O. Witzke, U. Duhrsen, R. Erbel, T. Philipp et al., Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13HUS: observational studies generate hypotheses that lead to randomized controlled trials, 34. Noris P, Balduini CL. Investigational drugs in thrombotic thrombocytopenic purpura, pp.1549-54382, 2006.